Pharmacogenomics of drug resistance in Breast Cancer Resistance Protein (BCRP) and its mutated variants

Distortion in spatial arrangement of amino acids in BCRP protein due to mutations led to low efficacy in drug response with respect to wild isoform. Results of present work demand to probe pharmacogenomic aspects in drug development efforts for breast cancer.